Skip to main content
Top
Published in: Acta Diabetologica 3/2013

01-06-2013 | Original Article

Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines

Authors: Maria Sambataro, Gianluca Perseghin, Guido Lattuada, Giampietro Beltramello, Livio Luzi, Giovanni Pacini

Published in: Acta Diabetologica | Issue 3/2013

Login to get access

Abstract

Adipokines are known to play a fundamental role in the etiology of obesity, that is, in the impaired balance between increased feeding and decreased energy expenditure. While the adipokine-induced changes of insulin resistance in obese diabetic and nondiabetic subjects are well known, the possible role of fat source in modulating insulin sensitivity (IS) remains controversial. The aim of our study was to explore in overweight type 2 diabetic patients (T2DM) with metabolic syndrome IS in different energy storage conditions (basal and dynamic) for relating it to leptin and adiponectin. Sixteen T2DM (5/11 F/M; 59 ± 2 years; 29.5 ± 1.1 kg/m2) and 16 control (CNT 5/11; 54 ± 2; 29.1 ± 1.0) underwent an oral glucose tolerance test. Fasting IS was measured by QUICKI, while the dynamic one with OGIS. The insulinogenic index (IGI) described beta cell function. Also, the lipid accumulation product parameter (LAP) was assessed. LAP accounts for visceral abdominal fat and triglycerides, and it is known to be related to IS. Possible interrelationships between LAP and adipokines were explored. In T2DM and CNT, adiponectin (7.4 ± 0.5 vs. 7.8 ± 0.9 μg/mL), leptin (13.3 ± 3.0 vs. 12.4 ± 2.6 ng/mL), and QUICKI (0.33 ± 0.01 vs. 0.33 ± 0.01) were not different (P > 0.40), at variance with OGIS (317 ± 11 vs. 406 ± 13 mL/min/m2; P = 0.006) and IGI (0.029 ± 0.005 vs. 0.185 ± 0.029 × 103 pmolI/mmolG; P = 0.00001). LAP was 85 ± 15 cm × mg/dL in T2DM and 74 ± 10 in CNT (P > 0.1), correlated with OGIS in all subjects (R = −0.42, P = 0.02) and QUICKI (R = −0.56, P = 0.025) in T2DM. Leptin correlated with QUICKI (R = −0.45, P = 0.009), and adiponectin correlated with OGIS (R = 0.43, P = 0.015). In overweight T2DM, insulin sensitivity in basal condition appears to be multifaceted with respect to the dynamic one, because it should be more fat-related. Insulin sensitivity appears to be incompletely described by functions of fasting glucose and insulin values alone and the use of other indices, such as LAP could be suggested.
Literature
2.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) Executive summary of the third report of the national cholesterol in adults (NCEP). JAMA 285:2486–2497 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) Executive summary of the third report of the national cholesterol in adults (NCEP). JAMA 285:2486–2497
3.
go back to reference Alberti KG, Zimmet P, Shaw J for IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome: a new worldwide definition. Lancet 366:1059–1062 Alberti KG, Zimmet P, Shaw J for IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome: a new worldwide definition. Lancet 366:1059–1062
4.
go back to reference Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association. Circulation 109:433–438PubMedCrossRef Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association. Circulation 109:433–438PubMedCrossRef
5.
go back to reference Grundy SM, Cleeman JI, Daniels SR (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752PubMedCrossRef
6.
go back to reference Khan R, Buse J, Ferrannini E, Stem M (2005) The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289–2304CrossRef Khan R, Buse J, Ferrannini E, Stem M (2005) The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289–2304CrossRef
7.
go back to reference Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, Papademetris X, Rothman DL, Shulman GI (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 31:12587–12594CrossRef Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, Papademetris X, Rothman DL, Shulman GI (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 31:12587–12594CrossRef
8.
go back to reference McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhom JN, Trischitta V, Florez JC for the ENPP1 Consortium (2008) The ENPP1 K121Q polymorphism is associated with T2DM in European population. Diabetes 57:1125–1130 McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhom JN, Trischitta V, Florez JC for the ENPP1 Consortium (2008) The ENPP1 K121Q polymorphism is associated with T2DM in European population. Diabetes 57:1125–1130
9.
go back to reference Dyck DJ, Heigenhauser GJF, Bruce CR (2006) The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol 186:5–16CrossRef Dyck DJ, Heigenhauser GJF, Bruce CR (2006) The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol 186:5–16CrossRef
10.
go back to reference Yudkin JS (2005) Vasocrine signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365:1817–1830PubMedCrossRef Yudkin JS (2005) Vasocrine signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365:1817–1830PubMedCrossRef
11.
go back to reference Shimizu H, Inoue K, Mori M (2007) The leptin-dependent and-independent melanocortin signaling system regulation of feeding and energy expenditure. J Endocrinol 193:1–9PubMedCrossRef Shimizu H, Inoue K, Mori M (2007) The leptin-dependent and-independent melanocortin signaling system regulation of feeding and energy expenditure. J Endocrinol 193:1–9PubMedCrossRef
12.
go back to reference Arner P (2005) Insulin resistance in type 2 diabetes—role of adipokines. Curr Mol Med 5:333–339PubMedCrossRef Arner P (2005) Insulin resistance in type 2 diabetes—role of adipokines. Curr Mol Med 5:333–339PubMedCrossRef
13.
go back to reference Shuldiner AR, Yang R, Gong DW (2001) Resistin, obesity, and insulin resistance—the emerging role of the adipocyte as an endocrine organ. N Engl J Med 345:1345–1346PubMedCrossRef Shuldiner AR, Yang R, Gong DW (2001) Resistin, obesity, and insulin resistance—the emerging role of the adipocyte as an endocrine organ. N Engl J Med 345:1345–1346PubMedCrossRef
14.
go back to reference Silha JV, Krsek M, Skrha MJV, Sucharda P, Nyomba GLG, Murphy LJ (2003) Plasma resistin, adiponectin and leptin level in lean and obese subjects. Correlation with insulin resistance. Eur J Endocrinol 149:331–335PubMedCrossRef Silha JV, Krsek M, Skrha MJV, Sucharda P, Nyomba GLG, Murphy LJ (2003) Plasma resistin, adiponectin and leptin level in lean and obese subjects. Correlation with insulin resistance. Eur J Endocrinol 149:331–335PubMedCrossRef
15.
go back to reference Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Canu T, Ragogna F, Scifo P, Del Maschio A, Luzi L (2007) Serum retinol-binding-4 leptin, and adiponectin concentrations are related to ectopic fat accumulation. J Clin Endocrinol Metab 92:4883–4888PubMedCrossRef Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Canu T, Ragogna F, Scifo P, Del Maschio A, Luzi L (2007) Serum retinol-binding-4 leptin, and adiponectin concentrations are related to ectopic fat accumulation. J Clin Endocrinol Metab 92:4883–4888PubMedCrossRef
16.
go back to reference Rabe K, Lehrke M, Parhofer KG, Broedl UC (2008) Adipokines and insulin resistance. Mol Med 14:741–751PubMedCrossRef Rabe K, Lehrke M, Parhofer KG, Broedl UC (2008) Adipokines and insulin resistance. Mol Med 14:741–751PubMedCrossRef
17.
go back to reference Hroussalas G, Kassi E, Dalamaga M, Delimaris I, Zachari A, Dionyssiou-Asteriou A (2008) Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women. Maturitas 59:339–349PubMedCrossRef Hroussalas G, Kassi E, Dalamaga M, Delimaris I, Zachari A, Dionyssiou-Asteriou A (2008) Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women. Maturitas 59:339–349PubMedCrossRef
18.
go back to reference Kahn SH (2005) The “lipid accumulation product’’ performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 5:26PubMedCrossRef Kahn SH (2005) The “lipid accumulation product’’ performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 5:26PubMedCrossRef
19.
go back to reference Kahn SH (2006) The lipid accumulation product is better than the body mass index for identifying diabetes. Diabetes Care 29:151–153PubMedCrossRef Kahn SH (2006) The lipid accumulation product is better than the body mass index for identifying diabetes. Diabetes Care 29:151–153PubMedCrossRef
20.
go back to reference Stein A, Myers GL (1994) Tietz textbook of clinical chemistry, 2nd edn. Saunders, New York Stein A, Myers GL (1994) Tietz textbook of clinical chemistry, 2nd edn. Saunders, New York
21.
go back to reference Perseghin G (2006) Serum resistin and hepatic fat content in nondiabetic individuals. J Clin Endocrinol Metab 91:5122–5125PubMedCrossRef Perseghin G (2006) Serum resistin and hepatic fat content in nondiabetic individuals. J Clin Endocrinol Metab 91:5122–5125PubMedCrossRef
22.
go back to reference Perseghin G (2001) Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab 86:3188–3196PubMedCrossRef Perseghin G (2001) Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab 86:3188–3196PubMedCrossRef
23.
go back to reference Koenig W, Sund M, Fröhlich M, Fischer HG, Lo H, Doring A, Hutchinson WL, Pepys MB for MONICA-Augsburg Cohort Study (1999). CRP, a sensitive marker for inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 99:237–42 Koenig W, Sund M, Fröhlich M, Fischer HG, Lo H, Doring A, Hutchinson WL, Pepys MB for MONICA-Augsburg Cohort Study (1999). CRP, a sensitive marker for inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 99:237–42
24.
go back to reference Balkau B, Deanfield JE, Despres JP, Bassand GP, Fox AAK, Smith SC Jr, Tan CE, Van Gal L, Wittchen HU, Massien C, Haffner SM (2007) International day for the evaluation of abdominal obesity (IDEA) study of waist circumference, cardiovascular disease, and diabetes mellitus in 168000 primary care patients in 63 countries. Circulation 116:1942–1951PubMedCrossRef Balkau B, Deanfield JE, Despres JP, Bassand GP, Fox AAK, Smith SC Jr, Tan CE, Van Gal L, Wittchen HU, Massien C, Haffner SM (2007) International day for the evaluation of abdominal obesity (IDEA) study of waist circumference, cardiovascular disease, and diabetes mellitus in 168000 primary care patients in 63 countries. Circulation 116:1942–1951PubMedCrossRef
25.
go back to reference Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410PubMedCrossRef Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410PubMedCrossRef
26.
go back to reference Abdul-Ghani MA, Matsuda M, Balas B, De Fronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94PubMedCrossRef Abdul-Ghani MA, Matsuda M, Balas B, De Fronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94PubMedCrossRef
27.
go back to reference Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548PubMedCrossRef Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548PubMedCrossRef
28.
go back to reference Sambataro M, Maioli M, Tonolo G, Stenhower CDA, van Hinsbergh VWM, Piarulli F, Nosadini R, Pacini G (2002) Insulin sensitivity correlates with glycogen synthesis rate, but not with von Willebrand factor in type 2 diabetes. Eur J Int Med 13:439–444CrossRef Sambataro M, Maioli M, Tonolo G, Stenhower CDA, van Hinsbergh VWM, Piarulli F, Nosadini R, Pacini G (2002) Insulin sensitivity correlates with glycogen synthesis rate, but not with von Willebrand factor in type 2 diabetes. Eur J Int Med 13:439–444CrossRef
29.
go back to reference Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, De Fronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance. Diabetes 55:1430–1435PubMedCrossRef Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, De Fronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance. Diabetes 55:1430–1435PubMedCrossRef
30.
go back to reference Abdul–Ghani MA, Tripathy D, De Fronzo RA (2006) Contributions of cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139PubMedCrossRef Abdul–Ghani MA, Tripathy D, De Fronzo RA (2006) Contributions of cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139PubMedCrossRef
31.
go back to reference Abdul-Ghani MA, Matsuda M, DeFronzo RA (2008) Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. Diabet Med 25:1289–1294PubMed Abdul-Ghani MA, Matsuda M, DeFronzo RA (2008) Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. Diabet Med 25:1289–1294PubMed
32.
go back to reference Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin, C-peptide: comparison of beta-cell function from OGTT, IVGTT. Diabetes Res Clin Pract 72:298–301PubMedCrossRef Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin, C-peptide: comparison of beta-cell function from OGTT, IVGTT. Diabetes Res Clin Pract 72:298–301PubMedCrossRef
33.
go back to reference de Piano A, Tock L, Carnier J, Oyama LM, Oller do Nascimento CM, Martinz AC, Foschini D, Sanches PL, Ernandes RM, de Mello MT, Tufik S, Dâmaso AR (2010) Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. Metabolism 59:613–619PubMedCrossRef de Piano A, Tock L, Carnier J, Oyama LM, Oller do Nascimento CM, Martinz AC, Foschini D, Sanches PL, Ernandes RM, de Mello MT, Tufik S, Dâmaso AR (2010) Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. Metabolism 59:613–619PubMedCrossRef
34.
go back to reference Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J (2006) Different mechanism for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29:1909–1914PubMedCrossRef Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J (2006) Different mechanism for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29:1909–1914PubMedCrossRef
35.
go back to reference Snijder MB, Dekker MJ, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC (2004) Hoorn study. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels. Diabetes Care 27:372–377PubMedCrossRef Snijder MB, Dekker MJ, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC (2004) Hoorn study. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels. Diabetes Care 27:372–377PubMedCrossRef
36.
go back to reference Snijder MB, Flyvbjerg A, Stehouwer CDA, Frystyk J, Henry RM, Seidell JC, Heine RJ, Dekker JM (2009) Relationship of adiposity with arterial stiffness as mediated by adiponectin in older man and women: the Hoorn Study. Eur J Endocrinol 160:87–95 Snijder MB, Flyvbjerg A, Stehouwer CDA, Frystyk J, Henry RM, Seidell JC, Heine RJ, Dekker JM (2009) Relationship of adiposity with arterial stiffness as mediated by adiponectin in older man and women: the Hoorn Study. Eur J Endocrinol 160:87–95
37.
go back to reference Finucane FM, Luan J, Wareham NJ, Sharp SJ, O’Rahilly S, Balkau B, Flyvbjerg A, Walker M, Højlund K, Nolan JJ, Savage DB (2009) Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52:2345–2349PubMedCrossRef Finucane FM, Luan J, Wareham NJ, Sharp SJ, O’Rahilly S, Balkau B, Flyvbjerg A, Walker M, Højlund K, Nolan JJ, Savage DB (2009) Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52:2345–2349PubMedCrossRef
38.
go back to reference Inoue M, Maehata E, Yano-Mtaniyama M, Suzuki S (2005) Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type two diabetes. Metabolism 54:281–286PubMedCrossRef Inoue M, Maehata E, Yano-Mtaniyama M, Suzuki S (2005) Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type two diabetes. Metabolism 54:281–286PubMedCrossRef
39.
go back to reference Avogaro A, Sambataro M, Marangoni A, Pianta A, Vettor R, Pagano C, Marescotti MC, Tiengo A, Beltramello G (2003) Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor alpha. J Endocrinol Invest 26:1213–1218PubMed Avogaro A, Sambataro M, Marangoni A, Pianta A, Vettor R, Pagano C, Marescotti MC, Tiengo A, Beltramello G (2003) Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor alpha. J Endocrinol Invest 26:1213–1218PubMed
40.
go back to reference Giorgino F, Laviola L, Eriksson JW (2005) Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 183:13–30PubMedCrossRef Giorgino F, Laviola L, Eriksson JW (2005) Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 183:13–30PubMedCrossRef
41.
go back to reference Giorgino F, Laviola L, Leonardini A (2005) Pathophysiology of T2DM: rationale for different oral antidiabetic treatment strategies. Diabetes Res Clin Pract 68:S22–S29PubMedCrossRef Giorgino F, Laviola L, Leonardini A (2005) Pathophysiology of T2DM: rationale for different oral antidiabetic treatment strategies. Diabetes Res Clin Pract 68:S22–S29PubMedCrossRef
Metadata
Title
Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines
Authors
Maria Sambataro
Gianluca Perseghin
Guido Lattuada
Giampietro Beltramello
Livio Luzi
Giovanni Pacini
Publication date
01-06-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-011-0366-x

Other articles of this Issue 3/2013

Acta Diabetologica 3/2013 Go to the issue

CONSENSUS PAPER

Trialogue

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.